TY  - GEN 
AU  - Blancas López-Barajas, María Isabel
AU  - Linares Rodríguez, Marina
AU  - Molero Mir, Maria D.
AU  - Garrido, José M.
AU  - Rodríguez Serrano, Fernando
PY  - 2023
UR  - https://hdl.handle.net/10481/84545
AB  - Purpose: Tamoxifen is a drug used for hormone receptor-positive breast cancers, primarily metabolised by the
CYP2D6 enzyme into active metabolites such as endoxifen. CYP2D6 displays varying degrees of activity
depending on its genotype. This study...
LA  - eng
PB  - Elsevier
KW  - Breast cancer
KW  - Tamoxifen
KW  - CYP2D6
KW  - Disease free-survival
KW  - Overall survival
TI  - Early increase in tamoxifen dose in CYP2D6 poor metaboliser breast cancer patients and survival: A propensity score matching analysis
DO  - 10.1016/j.breast.2023.03.012
ER  -